Showing results (581-590 of 6,664) with videos related to

Sort By:
Pageof 667
Annals of Hematology|March 24, 2019
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)Torsten Kessler, Steffen Koschmieder, Christoph Schliemann, et al.
Annals of Hematology|March 28, 2019
Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income countryMecneide Mendes Lins, Maria Julia Gonçalves Mello, Raul C Ribeiro, et al.
Annals of Hematology|March 28, 2019
Use of eltrombopag in aplastic anemia in EuropeMatyas Ecsedi, Étienne Lengline, Cora Knol-Bout, et al.
Annals of Hematology|March 29, 2019
Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysisT Demuynck, G Verhoef, M Delforge, et al.
Annals of Hematology|March 29, 2019
Allogeneic transplantation for high-risk chronic lymphocytic leukemia-a summary of a 16-year experienceGrzegorz Helbig, Adrianna Spałek, Agata Wieczorkiewicz-Kabut, et al.
Annals of Hematology|March 16, 2019
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective studySabrina Trudel, Benoît Tessoulin, Maxime Jullien, et al.
Annals of Hematology|February 5, 2014
Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemiaIgor F Domingos, Diego A Falcão, Betania L Hatzlhofer, et al.
Annals of Hematology|March 7, 2014
Inhibitor of differentiation 1 is a candidate prognostic marker in multicentric Castleman's diseaseChao Liu, Yi Ran Liu, Jian Chen, et al.
Annals of Hematology|February 16, 2017
Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysisYin Key Lai, Nai Ming Lai, Shaun Wen Huey Lee
Annals of Hematology|June 4, 2008
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemiaGunnar Cario, Andrea Fetz, Christian Bretscher, et al.
Pageof 667